Abstract:
The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein Q, X1, X2, R1 and Z are as defined herein.
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Abstract:
The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Abstract:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Abstract:
The present invention discloses an optical system with multiple optical lens having capability of auto-focus calibration, instead of conventional scheme of manual operations. Furthermore, achieve purpose of obtaining more accuracy in sharpness and magnification calibration than the conventionally scheme, and of upgrading yield rate of the system. The optical system disclosed by the invention basically includes a lot of home-sensors and micro-sensors, lots of lens, an image sensor, an imaging control motor, a lens switch motor for switching the lens, and a base control motor for switching base of the optical system. By using the imaging control motor and the base control motor to control motions of the imaging device and the lens, auto sharpness and magnification calibration is easily achieved.
Abstract:
A lens switching apparatus for a dual-lens optical scanner includes a base, a plurality of magnetic elements, a plurality of electromagnetic elements, a guiding assembly and a slide block. Two optical lens with different magnification are mounted on the slide block. The slide block may be moved and positioned in one direction when one of the electromagnetic element attracting one adjacent magnetic element while another electromagnetic element repulsive another adjacent magnetic element. The dual-lens mounted on the slide block thus can be switched as desired for scanning process.
Abstract:
A dimming ballast system wherein the light output of the lamp is controlled by a remote source. The ballast output voltage is regulated by a voltage control feedback loop, the dimming function being achieved by varying the set point of the control loop. The remote control signal, coded by interrupting the current flow to the ballast for a short period, is processed digitally by a microcomputer which generates information to vary the control set point. Circuit means are provided to control the filament voltage of the fluorescent lamps such that as the lamps are dimmed down, the filament voltage is maintained or slightly increased, thus prolonging lamp life and stabilizing the lamp light output.
Abstract:
An LED lamp has a PCB at least partially made of metal and a base configured to receive the PCB in a slot formed on the base. The base has a base top surface and the slot has a tapered cross-section. A first sidewall is formed in the slot. The first sidewall is formed at a first sidewall angle that is less than 90°. A second sidewall is formed in the slot. The second sidewall is formed at a second sidewall angle. A top protrusion is formed on a base top surface. The top protrusion has a top protrusion first position and a top protrusion second position. A pair of edges are formed on the PCB, namely a first edge formed on the PCB and a second edge formed on the PCB. The first edge is tapered to engage the first sidewall.